Axillary Surgical Attitude Changing with Retrospective Application of ACOSOG Z0011 Eligible Criteria: An Institutional Evaluation
- PMID: 37795004
- PMCID: PMC10546802
- DOI: 10.4274/ejbh.galenos.2023.2023-6-4
Axillary Surgical Attitude Changing with Retrospective Application of ACOSOG Z0011 Eligible Criteria: An Institutional Evaluation
Abstract
Objective: Sentinel lymph node biopsy (SLNB) represents the gold standard for axillary surgical staging. The aim of this study was to assess the proportion of axillary lymph node dissection (ALND) that could be avoided after retrospective application of the ACOSOG Z0011 criteria and to evaluate the shortterm complications associated with axillary surgery.
Materials and methods: We reviewed breast cancer (BC) patients treated by primary breast-conserving surgery from 2012 to 2015. The percentage of SLNB vs ALND performed before and after the application of the ACOSOG Z0011 criteria was calculated. Complications were analyzed using crosstabs, with p<0.05 considered significant.
Results: Two hundred fifty one patients with a median age of 59.3 years were included. BC tumors had a median size of 13 mm and were mostly unifocal (83.9%). There were 30.3% with 1-2 metastatic lymph nodes (MLN). ALND was performed in 44.2%. The patients with 1-2 MLN, had only SLNB in 14.5% of cases. By applying the ACOSOG Z0011 criteria, ALND would have been avoided in 40.2% of patients. At least one postoperative complication was reported after SLNB or ALND for 45.7% and 74.7% of patients respectively. Seroma was the most frequent complication, and occurred in 29.3% of cases after SLNB and in 59.5% after ALND.
Conclusion: SNLB is the most commonly used axillary surgical staging procedure in this series (55.8%). With a retrospective application of the ACOSOG Z0011 criteria in our population, ALND could have been avoided for 40.2% patients. Post-operative complications rate was higher after ALND, with a seroma rate at 59.5%.
Keywords: Breast-conserving surgery; axillary lymph node dissection; axillary surgery; sentinel lymph node biopsy; seroma.
©Copyright 2023 by the the Turkish Federation of Breast Diseases Societies / European Journal of Breast Health published by Galenos Publishing House.
Conflict of interest statement
Conflict of Interest: No conflict of interest was declared by the authors.
Figures

Similar articles
-
Impact of axillary dissection in women with invasive breast cancer who do not fit the Z0011 ACOSOG trial because of three or more metastatic sentinel lymph nodes.Eur J Surg Oncol. 2015 Aug;41(8):998-1004. doi: 10.1016/j.ejso.2015.04.003. Epub 2015 Apr 25. Eur J Surg Oncol. 2015. PMID: 25986854 Clinical Trial.
-
National Trend of Axillary Management in Clinical T3/T4 N0 Patients Having Breast Conserving Therapy.J Surg Res. 2020 Nov;255:361-370. doi: 10.1016/j.jss.2020.05.073. Epub 2020 Jun 27. J Surg Res. 2020. PMID: 32599456
-
Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort.Bull Cancer. 2022 Mar;109(3):268-279. doi: 10.1016/j.bulcan.2021.09.018. Epub 2021 Nov 24. Bull Cancer. 2022. PMID: 34838310
-
Axillary Management in Women with Early Breast Cancer and Limited Sentinel Node Metastasis: A Systematic Review and Metaanalysis of Real-World Evidence in the Post-ACOSOG Z0011 Era.Ann Surg Oncol. 2021 Feb;28(2):920-929. doi: 10.1245/s10434-020-08923-7. Epub 2020 Jul 23. Ann Surg Oncol. 2021. PMID: 32705512
-
Evolution of axillary nodal staging in breast cancer: clinical implications of the ACOSOG Z0011 trial.Cancer Control. 2012 Oct;19(4):267-76. doi: 10.1177/107327481201900403. Cancer Control. 2012. PMID: 23037494 Review.
Cited by
-
Effects of BMI on prognosis, disease-free survival and overall survival of breast cancer.BMC Cancer. 2025 Feb 13;25(1):257. doi: 10.1186/s12885-025-13638-7. BMC Cancer. 2025. PMID: 39948483 Free PMC article.
References
-
- Canavese G, Catturich A, Vecchio C, Tomei D, Gipponi M, Villa G, et al. B. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol. 2009;20:1001–1007. - PubMed
-
- Costaz H, Rouffiac M, Boulle D, Arnould L, Beltjens F, Desmoulins I, et al. Stratégies en cas de positivité du ganglion sentinelle dans les cancers du sein [Strategies in case of metastatic sentinel lymph node in breast cancer] Bull Cancer. 2020;107:672–685. - PubMed
LinkOut - more resources
Full Text Sources